Ilika plc Collaboration with PragmatIC and Arm Holdings

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, announced today a collaboration with PragmatIC and Arm Holdings Plc (LON:ARM) to further progress development in ultra-thin and flexible semiconductor technology for mass market applications.

The 18-month project is supported by Innovate UK funding of £0.6m of which £0.4m will be payable to Ilika.

The principal objective of this collaboration is to deliver novel P-type metal-oxide semiconductor (‘PMOS’) circuit technology that can significantly enhance the characteristics of PragmatIC’s CMOS designs. The project focusses on investigating the operarting parameters of PMOS, using Ilika’s high throughput thin-film techniques which are proven for rapid identification and screening of functional thin-film materials. The initial phase of the project is intended to demonstrate the innovative thin film transistor performance, which is to be followed by scale-up and transfer of the material to deposition processes in a production environment.

Market Opportuntity

Ultra low-power and ultra low-cost flexible electronics provide the opportunity to add functionality to many items, as well as extending proven applications such as RFID and NFC into mass-market use cases that were previously prohibited by the cost of traditional silicon integreted circuits (‘ICs’). The first application for these flexible ICs (‘FlexICs’) is the smart packaging market which is predicted to grow at CAGR of 8% to a projected value of $7.8 billion by 2021, according to Smithers Pira.

This collaboration intends to develop technology that can potentially accelerate the progression of FlexICs along their own Moore’s Law, with higher integration, lower power and costs, which will produce FlexICs suitable for many more market segments including applications for advanced authentication and security applications.

Dr. Richard Rice, PragmatIC CTO, stated: “This collaboration will build on our previous work under Innovate UK’s COSMOS project. By partnering with Ilika and Arm we look forward to augmenting our technology roadmap and enabling the development of future FlexICs.”

Commenting on this collaboration, Graeme Purdy, Ilika Plc CEO, said: “This collaboration is a strong fit with our technology capability in rapidly developing novel thin-film materials and devices. A successful outcome would enable the collaboration partners to address large global markets in this disruptive sector. This programme is expected to yield a complementary IoT-focused technology alongside our StereaxÔ M250 solid-state batteries.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Search